Northwestern Mutual Wealth Management CO Aerie Pharmaceuticals Inc Transaction History

Northwestern Mutual Wealth Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $2,274 - $2,845	-150 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $1,967 - $3,135	150 New	150 $3,000
Q1 2020 May 08, 2020	SELL	$11.84 - $25.52 $1,894 - $4,083	-160 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.72 - $25.1 $2,480 - $3,514	-140 Reduced 46.67%	160 $4,000
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $5,523 - $8,400	300 New	300 $6,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.